Education & Training
Educating the next generation of clinical/translational scientists
Home » Education & Training » Here
In this section
Translational Research for Advanced Doctoral Students
A weekly 8 a.m. seminar on biostatistics for graduate students at The Scripps Research Institute who are participating in STSI’s Translational Research for Advanced Doctoral Students program. Scripps Health physicians who are STSI scholars also are required to attend this seminar as well as other classes sponsored by STSI’s education and training program.
A core component of The Scripps Research Institute (TSRI) and its Kellogg School of Science and Technology is to educate and train the upcoming generation of biomedical scientists. The Translational Research for Advanced Doctoral Students (TL-1) program focuses on the support and development of TSRI doctoral candidates seeking careers in translational bio-scientific research. The TL-1 program introduces and then integrates doctoral science candidates to the principles of applied biostatistics, genomics, molecular medicine, and clinical trial design and execution via seminar participation with physician-scientists. In short order the doctoral candidate is integrated into the clinical world by working alongside medical clinicians who have a basic/translational science interest and/or practice. The doctoral candidate then develops a research hypothesis and plan wherein he/she collaborates with clinical investigators in seeking a translational solution to an unsolved clinical problem.
The Scripps Translational Science Institute (STSI) emphasizes three dimensions of translational science: traditional bench to bedside, bedside to bench and back to bedside, and bedside to the community and practice of medicine. The vision of this program provides the appropriate amalgam of “integration and innovation” and opportunity to capitalize on the particular strengths of TSRI, Scripps Health, and partnering institutions and faculty members that have led to the development of the goals of the STSI.
Building upon and establishing specific collaborations with leading translational science and clinical investigators will accelerate discovery that has impact across multiple research disciplines. Collaborations with a large subset of the 550 life science companies in San Diego provide an extraordinary advantage for accessing innovative technology and catalyzing benefits to patients. STSI exploits the excitement of today’s scientific advances to advance tomorrow’s preventions, betterment of health, and the training of the future leaders of academic medicine.